4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-013531
Options or other derivatives
- Chief Medical Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2019-02-22 | Grant or award · Stock option (right to buy) | +40,000 | 40,000 | D | ||
| Bowden Christopher Chief Medical Officer | 2019-02-22 | Grant or award · Restricted stock units | +10,000 | 10,000 | D | ||
Loading xslF345X03/doc4.xml…